These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 21272035)

  • 1. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
    Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
    Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
    Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
    Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved FcγRIIb targeting functionally translates into enhanced inhibition of basophil activation.
    Buschor P; Eggel A; Zellweger F; Stadler BM; Vogel M
    Int Arch Allergy Immunol; 2014; 163(3):206-14. PubMed ID: 24557487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
    Gomez G
    Front Immunol; 2019; 10():175. PubMed ID: 30792720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.
    Zhu D; Kepley CL; Zhang M; Zhang K; Saxon A
    Nat Med; 2002 May; 8(5):518-21. PubMed ID: 11984598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.
    Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A
    J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
    Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
    J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
    Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
    Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
    Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
    Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of an Fcgamma-Fc(epsilon)-fusion protein in house dust mite sensitive nonhuman primates.
    Van Scott MR; Mertsching E; Negrou E; Miles J; Stallings HW; Graff C; Kehry MR
    Clin Immunol; 2008 Sep; 128(3):340-8. PubMed ID: 18583194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW; Demissie S; Thomas D; Daëron M
    Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
    Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
    J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does IgE bind to and activate eosinophils from patients with allergy?
    Kita H; Kaneko M; Bartemes KR; Weiler DA; Schimming AW; Reed CE; Gleich GJ
    J Immunol; 1999 Jun; 162(11):6901-11. PubMed ID: 10352312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.
    Saxon A; Zhu D; Zhang K; Chan LA; Kepley CL
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):223-31; discussion 231-3. PubMed ID: 17393744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge.
    Christensen LH; Holm J; Lund G; Riise E; Lund K
    J Allergy Clin Immunol; 2008 Aug; 122(2):298-304. PubMed ID: 18572230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.